| Structure | Chemical Name | CAS | MF |
|
1-Propanol,2,2-difluoro-,benzoate(9CI)
|
784193-14-2
|
C10H10F2O2
|
|
2,2-Difluoropropyl trifluoromethanesulfonate
|
784193-15-3
|
C4H5F5O3S
|
|
3-BroMo-4-nitropyrazole
|
784193-37-9
|
C3H2BrN3O2
|
|
(S)-N-(2-(4-(tert-butyl)-4,5-dihydrooxazol-2-yl)phenyl)-1-phenylmethanesulfonamide
|
784194-02-1
|
C20H24N2O3S
|
|
2-[(4-chlorophenyl)amino]-5-nitrobenzonitrile
|
784194-67-8
|
C13H8ClN3O2
|
|
2-Thiophenecarboxamide,N-(4-ethylphenyl)-3-methyl-(9CI)
|
784195-61-5
|
C14H15NOS
|
|
Benzamide, 3,5-difluoro-N-(5-methyl-2-thiazolyl)- (9CI)
|
784197-89-3
|
C11H8F2N2OS
|
|
2-Butanone,4-[(1S,3R)-2,2-dimethyl-3-(5-methyl-1,4-cyclopentadien-1-yl)cyclopropyl]-(9CI)
|
784201-51-0
|
C15H22O
|
|
2H-Pyran,3,4-dihydro-2,2,6-trimethyl-3-[(E)-(2-methyl-2-cyclopenten-1-ylidene)methyl]-,(3S)-(9CI)
|
784201-52-1
|
C15H22O
|
|
2-Oxabicyclo[2.2.1]heptane,1,3,3-trimethyl-7-(5-methyl-1,4-cyclopentadien-1-yl)-,(1R,4S,7S)-rel-(9CI)
|
784201-53-2
|
C15H22O
|
|
Cyclobut[e]azulen-4-ol, 2a,3,4,5,5a,6,7,8,8a,8b-decahydro-2,8-dimethyl-5-methylene-, (2aR,4S,5aS,8R,8aS,8bR)-rel- (9CI)
|
784201-55-4
|
C15H22O
|
|
1.6-Chloro-4-methyl-1(2H)-phthalazinone
|
784203-75-4
|
C9H7ClN2O
|
|
RGB-286638
|
784210-87-3
|
C29H37Cl2N7O4
|
|
RGB-286638 (free base)
|
784210-88-4
|
C29H35N7O4
|
|
Cdk/Crk Inhibitor
|
784211-09-2
|
C23H22Cl2N4O3
|
|
Ethanone, 1-(4-methylene-1,5-cyclohexadien-1-yl)- (9CI)
|
784213-29-2
|
C9H10O
|
|
1,5-Cyclohexadiene-1-carboxylicacid,4-methylene-,methylester(9CI)
|
784213-30-5
|
C9H10O2
|
|
1,5-Cyclohexadiene-1-carboxamide,4-methylene-(9CI)
|
784213-33-8
|
C8H9NO
|
|
Proline, 5-(4-methylphenyl)- (9CI)
|
784984-08-3
|
C12H15NO2
|
|
1H-Pyrazole-3-propanoicacid,alpha-amino-,methylester,(S)-(9CI)
|
784984-83-4
|
C7H11N3O2
|
|
Boronic acid, [3-(dimethylamino)propyl]- (9CI)
|
784985-28-0
|
C5H14BNO2
|
|
4(3H)-Quinazolinone, 3-[3-(ethylmethylamino)-2-hydroxypropyl]-6,7,8-trimethoxy-2-methyl-
|
784986-26-1
|
C18H27N3O5
|
|
Pyridine, 1,2,5,6-tetrahydro-1,2,5-trimethyl-4-phenyl-, cis- (9CI)
|
784986-58-9
|
C14H19N
|
|
3-Buten-2-one,4-(2-imino-3(2H)-thiazolyl)-(9CI)
|
784987-01-5
|
C7H8N2OS
|
|
2,4,6(1H,3H,5H)-Pyrimidinetrione,5-butyl-1-ethyl-5-methyl-(9CI)
|
784987-86-6
|
C11H18N2O3
|
|
Tyrosine, -alpha--ethyl-3,5-dimethoxy-O-methyl--bta--oxo-, methyl ester
|
784987-88-8
|
C15H21NO6
|
|
Guanidine, N-butyl-N-(4,5-dihydro-4,4-dimethyl-1H-imidazol-2-yl)- (9CI)
|
784988-60-9
|
C10H21N5
|
|
2,5-Methano-2H-cyclopenta[c]pyridine,octahydro-(9CI)
|
784989-03-3
|
C9H15N
|
|
5-Benzofuranol,3-[(dimethylamino)methyl]-2,3-dihydro-2,2-dimethyl-(9CI)
|
784990-15-4
|
C13H19NO2
|
|
Imidazo[2,1-b]quinazolin-2(3H)-one, 7-amino-1,5-dihydro-6-methyl- (9CI)
|
784992-00-3
|
C11H12N4O
|
|
Hydrazinecarboximidamide, 2-(2,3-dihydro-5-methyl-1H-inden-1-ylidene)- (9CI)
|
784992-02-5
|
C11H14N4
|
|
4(3H)-Pyrimidinone,6-hydroxy-2,3-dimethyl-(9CI)
|
784995-34-2
|
C6H8N2O2
|
|
Butanoic acid, 3-methyl-2-[(4-methyl-3-cyclohexen-1-yl)oxy]- (9CI)
|
784995-91-1
|
C12H20O3
|
|
1-[4-(pyrrolidin-1-ylsulfonyl)phenyl]methanamine
|
784997-49-5
|
C11H16N2O2S
|
|
1H-3-Benzazepine-7,8-diol, 3-(2-hydroxyethyl)-2,3,4,5-tetrahydro- (9CI)
|
784999-07-1
|
C12H17NO3
|
|
4-Thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylicacid,6-acetyl-3-methyl-7-oxo-,cis-(9CI)
|
784999-23-1
|
C9H9NO4S
|
|
1,3-Oxathiolane-5-thione,2-butyl-4-imino-2-methyl-(9CI)
|
784999-81-1
|
C8H13NOS2
|
|
2H-Imidazo[4,5-c]pyridin-2-one, 7-amino-1,3-dihydro-
|
784999-93-5
|
C6H6N4O
|
|
2H-Pyrazino[1,2-c]quinazolin-1(11bH)-one,3,4-dihydro-6-methyl-(9CI)
|
785001-69-6
|
C12H13N3O
|
|
L-Proline,4-cyclohexyl-,cis-
|
785001-74-3
|
C11H19NO2
|
|
Pyrido[3,4-b]pyrazin-3-amine, 5,6,7,8-tetrahydro-6-methyl- (9CI)
|
785001-75-4
|
C8H12N4
|
|
Benzeneethanimidic acid, 3-chloro--alpha--hydroxy-6-methoxy-2-methyl-, ethyl ester (9CI)
|
785001-76-5
|
C12H16ClNO3
|
|
1H-Pyrazol-5-amine,1-(2-amino-4-methoxyphenyl)-3-methyl-(9CI)
|
785003-65-8
|
C11H14N4O
|
|
2H-Naphth[1,2-b]-1,4-oxazine,4-ethyl-3,4,4a,5,6,10b-hexahydro-,trans-(-)-(9CI)
|
785004-00-4
|
C14H19NO
|
|
3-Piperidinol,2-[(2-methylphenyl)methyl]-,trans-(9CI)
|
785004-60-6
|
C13H19NO
|
|
4,6,7-Isoquinolinetriol,1,2,3,4-tetrahydro-1,2-dimethyl-,trans-(9CI)
|
785005-23-4
|
C11H15NO3
|
|
Methanesulfonic acid, [(2-chloroethyl)amino]oxo- (9CI)
|
785006-00-0
|
C3H6ClNO4S
|
|
2-Thiopheneaceticacid,alpha-[(2-aminoethyl)amino]-5-methyl-(9CI)
|
785006-46-4
|
C9H14N2O2S
|
|
1H-1,2,4-Triazole,1-(4H-1,2,4-triazol-4-ylmethyl)-(9CI)
|
785010-95-9
|
C5H6N6
|
|
Urea, N-(2-hydroxy-1-oxido-4-pyridinyl)-N-(1-methylethyl)- (9CI)
|
785011-08-7
|
C9H14N3O3-
|
|
Piperazine, 1-methyl-4-[(3-methyl-1-piperidinyl)carbonyl]- (9CI)
|
785011-13-4
|
C12H23N3O
|
|
1,2-Propanediamine,N2-(ethylcarbonimidoyl)-N1,N1-dimethyl-(9CI)
|
785011-97-4
|
C8H17N3
|
|
6-Benzothiazolol, 4,5,7-trimethyl-2-(methylamino)-
|
785012-07-9
|
C11H14N2OS
|
|
Benzamide, 4-[(aminoiminomethyl)amino]-N-pyrazinyl- (9CI)
|
785013-66-3
|
C12H12N6O
|
|
2-Furanethanimidamide,alpha-amino-N-hydroxy-(9CI)
|
785014-77-9
|
C6H9N3O2
|
|
3-Cyclohexene-1-carboxylicacid,2-amino-,(1R-trans)-(9CI)
|
785015-46-5
|
C7H11NO2
|
|
2-Bromo-4-(2,4,6-trimethylphenyl)thiazole
|
785016-90-2
|
C12H12BrNS
|
|
4-Pyridinemethanamine,1,4-dihydro-1-methyl-2-(phenylmethyl)-(9CI)
|
785017-08-5
|
C14H18N2
|
|
Quinoline, 2-(2,5-dihydro-1H-imidazol-2-yl)-3-methyl- (9CI)
|
785017-43-8
|
C13H13N3
|
|
Ethanimidamide, N-(4-ethylphenyl)-N-2-propynyl- (9CI)
|
785018-43-1
|
C13H16N2
|
|
3-Isoquinolinecarboxylic acid, 1,2,3,4-tetrahydro-7,8-dihydroxy-, methyl ester (9CI)
|
785018-58-8
|
C11H13NO4
|
|
Cyclohexanepropanamine, gamma-methyl- (9CI)
|
785018-97-5
|
C10H21N
|
|
Benzenepropanimidic acid, 4-methyl-ba-oxo-, ethyl ester (9CI)
|
785019-14-9
|
C12H15NO2
|
|
Pyrido[2,3-d]pyrimidine-6-carboxaldehyde, 2-amino-4,8-dihydro-8-methyl-4-oxo- (9CI)
|
785019-42-3
|
C9H8N4O2
|
|
Morpholine, 2-(4-fluorophenyl)-3,5-dimethyl-, [2S-(2alpha,3ba,5ba)]- (9CI)
|
785019-72-9
|
C12H16FNO
|
|
4-Pyrimidinamine,2,6-diethyl-(9CI)
|
785020-52-2
|
C8H13N3
|
|
2H-Imidazol-2-imine,1,3-dihydro-1-methyl-3-propyl-(9CI)
|
785021-21-8
|
C7H13N3
|
|
2-Oxazolidinone, 3-(1-hydroxyethenyl)-4-(1-methylethyl)-, (S)- (9CI)
|
785021-63-8
|
C8H13NO3
|
|
4-Piperidinecarboxylic acid, 3-methyl-4-phenyl-, (3S,4R)-
|
785021-81-0
|
C13H17NO2
|
|
4-Piperidinone,2-(mercaptomethyl)-1-methyl-(9CI)
|
785026-23-5
|
C7H13NOS
|
|
Guanidine, N-[3-(aminomethyl)-4-ethylphenyl]-N-ethyl- (9CI)
|
785027-16-9
|
C12H20N4
|
|
2-Imidazolidinone,1-[2-(ethylamino)ethyl]-(9CI)
|
785027-35-2
|
C7H15N3O
|
|
2-Propenamide,N-methyl-N-[2-(methylamino)ethyl]-(9CI)
|
785030-60-6
|
C7H14N2O
|
|
1-(1-(2-chlorophenyl)ethyl)hydrazine
|
785031-97-2
|
C8H11ClN2
|
|
3-BroMo-N-Methyl-benzeneethanaMine
|
785032-26-0
|
C9H12BrN
|
|
Phosphonic acid, [2-(2-methyl-1,3-dioxolan-2-yl)-2-oxoethyl]- (9CI)
|
785034-43-7
|
C6H11O6P
|
|
1H-Pyrrolizine,hexahydro-2-methylene-(9CI)
|
785034-65-3
|
C8H13N
|
|
D-Proline, 2-methyl-3-phenyl-, (3S)-rel- (9CI)
|
785034-74-4
|
C12H15NO2
|
|
2H-Pyrrol-5-amine,3,4-dihydro-2-[(4-methoxyphenyl)methyl]-3-methyl-,(2R,3S)-rel-(9CI)
|
785035-14-5
|
C13H18N2O
|
|
Pentanamide, 2,5-diamino-N,N-dimethyl-, (2S)- (9CI)
|
785035-72-5
|
C7H17N3O
|
|
3aH-Indeno[1,2-d]thiazol-3a-ol,8,8a-dihydro-2-methyl-(9CI)
|
785035-84-9
|
C11H11NOS
|
|
2-Cyclohexen-1-one,2-[(dimethylamino)methyl]-3-hydroxy-(9CI)
|
785035-91-8
|
C9H15NO2
|
|
1,4-Benzenediamine, N1-(4,5-dihydro-1H-imidazol-2-yl)-
|
785036-20-6
|
C9H12N4
|
|
(R)-3-Amino-4-(3-chlorophenyl)butanoic acid
|
785038-49-5
|
C10H12ClNO2
|
|
2H-Pyrrol-5-amine,N-(dicyclopropylmethyl)-3,4-dihydro-2,3-dimethyl-,(2R,3S)-rel-(9CI)
|
785038-80-4
|
C13H22N2
|
|
H-Tyr-Phe-Lys-Ala-NH2
|
785039-30-7
|
C27H38N6O5
|
|
1,3,5-Triazine-2,4-diamine,1,6-dihydro-N,N-dimethyl-(9CI)
|
785039-33-0
|
C5H11N5
|
|
1,2-Cyclopentanediol,4-amino-3-(hydroxymethyl)-5-methoxy-,(1R,2R,3R,4S,5R)-rel-(9CI)
|
785039-57-8
|
C7H15NO4
|
|
Benzenesulfonic acid, 4-[[(4-amino-1-butyl-1,2,3,6-tetrahydro-2,6-dioxo-5-pyrimidinyl)amino]carbonyl]-
|
785041-28-3
|
C15H18N4O6S
|
|
1H-Pyrazole-1-ethanol, 4,5-diamino--alpha--methyl-
|
785042-35-5
|
C6H12N4O
|
|
2,6-Methano-3-benzazocin-10-ol,1,2,3,4,5,6-hexahydro-6-methyl-(9CI)
|
785042-48-0
|
C13H17NO
|
|
3-chloro-2-Pyridinecarboximidamide
|
785043-56-3
|
C6H6ClN3
|
|
D-erythro-Pentonic acid, 4-amino-2,5-anhydro-3,4-dideoxy-, methyl ester (9CI)
|
785044-07-7
|
C6H11NO3
|
|
1H-Furo[2,3-c]pyrazolium, 4-(ethoxycarbonyl)-2,5-dimethyl-3-[(1-methyl-4(1H)-pyridinylidene)methyl]-1-phenyl-
|
785044-56-6
|
C23H24N3O3+
|
|
Cyclopentanecarboxylic acid, 2-amino-4-pentylidene-, (1R,2S)-rel- (9CI)
|
785045-27-4
|
C11H19NO2
|
|
Benzoic acid, 2-[[2-[(2-carboxyphenyl)amino]-5-(trifluoromethyl)phenyl]amino]-5-[[[(4-methoxyphenyl)methyl]amino]methyl]-
|
785046-93-7
|
C30H26F3N3O5
|
|
1H-Imidazole-4-carboxamide,5-amino-N-(2-methylphenyl)-(9CI)
|
785047-62-3
|
C11H12N4O
|
|
1-Propanone, 2-amino-1-[4-(propylthio)phenyl]-
|
785048-82-0
|
C12H17NOS
|
|
[1,2,4]Triazolo[1,5-a]pyrazin-8-amine, 6-bromo-2-(2-furanyl)-
|
785048-93-3
|
C9H6BrN5O
|
|
1-Pyrrolidinecarboxylic acid, 3-ethynyl-, 1,1-dimethylethyl ester, (3S)-
|
785051-40-3
|
C11H17NO2
|